PUK vs NMR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 25, 2026

PUK

44.4
AI Score
VS
PUK Wins

NMR

38.3
AI Score

Investment Advisor Scores

PUK

44score
Recommendation
HOLD

NMR

38score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric PUK NMR Winner
Forward P/E 9.7371 15.3846 PUK
PEG Ratio 2.4341 0.8146 NMR
Revenue Growth -1.8% 31.2% NMR
Earnings Growth -23.0% 42.0% NMR
Tradestie Score 44.4/100 38.3/100 PUK
Profit Margin 25.5% 17.3% PUK
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY PUK

Relative Price Performance (Last 90 Days)

PUK 1M: -10.1% · 3M: -12.8% NMR 1M: -5.2% · 3M: +4.4%

Current Technical Phase

PUK

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.8%), weak momentum, RSI 26

RSI (14): 25.6 · Price: $24.54

NMR

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 40

RSI (14): 39.8 · Price: $9.72

Fundamentals Snapshot

Metric PUK NMR
Market Cap — —
Forward P/E 15.4 13.1
Trailing P/E 8.7 11.6
Revenue (TTM) — —
Revenue Growth 0.0% 0.3%
Gross Margin 0.4% 0.8%
Operating Margin 0.3% 0.3%
EPS 2.84 0.84
Dividend Yield 0.01% 0.03%

Frequently Asked Questions

Based on our detailed analysis, PUK is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.